| 产品名称 | Imanis Life Sciences | CL183 | Nalm6-Fluc-Puro/HuCD19-Puro (mid) |
|---|---|
| 目录号 | CL183 |
| 别名 | Nalm6-Fluc-Puro/HuCD19-Puro (mid) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| CL183 | 咨询 | 咨询 |
Imanis Life Sciences | CL183 | Nalm6-Fluc-Puro/HuCD19-Puro (mid)
品名：Nalm6-Fluc-Puro/HuCD19-Puro (mid)
货号：CL183
品牌：Imanis Life Sciences
产品描述
Species：Human
Cell Type：Chronic Myelogenous Leukemia
Transgene：Firefly luciferase (Fluc; Luc2), Human CD19 (HuCD19)
Selection Gene：Puromycin resistance (Puro)
The Nalm6-Fluc-Puro/HuCD19-Puro (mid) cell line stably expresses firefly luciferase and levels of human CD19 that are below the endogenous levels normally observed in Nalm6 cells (see Characterization tab for data). The cells are designed for in vitro and in vivo studies of tumor cells expressing CD19. These cells can be used in combination with other Imanis Nalm6-Fluc-Puro cell lines that are part of the CD19 panel comprised of Nalm6-Fluc-Puro cells with various CD19 surface receptor densities: Nalm6-Fluc-Puro (endogenous (high) levels of CD19) Nalm6-Fluc-Puro/CD19-KO (negative for CD19) Nalm6-Fluc-Puro/HuCD19-Puro (low) (moderate levels of CD19) To generate this cell line, Nalm6-Fluc-Puro/CD19-KO cells were transduced with a human CD19-encoding lentivirus. A moderate HuCD19 expressing population was generated by selection using a methylcellulose based semi-solid medium. This cell line has been tested for mycoplasma contamination and is certified mycoplasma free. The parental Nalm6 cell line was licensed and purchased directly from ATCC*. *The ATCC trademark and trade name and any and all ATCC catalog numbers are trademarks of the American Type Culture Collection.
